Industry: Chemical & Material
Published Date: 2024-01-15
Pages: 103 Pages
Report ld: 2642956
Request Sample
Customized Report
Alpha-GPC Market Size(US$)

CAGR 2024-2030
5.7%
Market Size,2030
USD 101.2
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias.
Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. It is a non-prescription drug in most countries. The FDA determined that intake of no more than 196.2 mg/person/day is considered generally recognized as safe (GRAS).
The global market for Alpha-GPC was estimated to be worth US$ 69 million in 2023 and is forecast to a readjusted size of US$ 101.2 million by 2030 with a CAGR of 5.7% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Alpha-GPC, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Alpha-GPC by region & country, by Type, and by Application.
The Alpha-GPC market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-GPC.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Alpha-GPC manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Alpha-GPC in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Alpha-GPC in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Alpha-GPC Product Introduction
1.2 Global Alpha-GPC Market Size Forecast
1.2.1 Global Alpha-GPC Sales Value (2019-2030)
1.2.2 Global Alpha-GPC Sales Volume (2019-2030)
1.2.3 Global Alpha-GPC Sales Price (2019-2030)
1.3 Alpha-GPC Market Trends & Drivers
1.3.1 Alpha-GPC Industry Trends
1.3.2 Alpha-GPC Market Drivers & Opportunity
1.3.3 Alpha-GPC Market Challenges
1.3.4 Alpha-GPC Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Alpha-GPC Players Revenue Ranking (2023)
2.2 Global Alpha-GPC Revenue by Company (2019-2024)
2.3 Global Alpha-GPC Players Sales Volume Ranking (2023)
2.4 Global Alpha-GPC Sales Volume by Company Players (2019-2024)
2.5 Global Alpha-GPC Average Price by Company (2019-2024)
2.6 Key Manufacturers Alpha-GPC Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Alpha-GPC Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Alpha-GPC
2.9 Alpha-GPC Market Competitive Analysis
2.9.1 Alpha-GPC Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Alpha-GPC Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-GPC as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Liquid Glycerophosphorylcholine
3.1.2 Powder Glycerophosphorylcholine
3.2 Global Alpha-GPC Sales Value by Type
3.2.1 Global Alpha-GPC Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Alpha-GPC Sales Value, by Type (2019-2030)
3.2.3 Global Alpha-GPC Sales Value, by Type (%) (2019-2030)
3.3 Global Alpha-GPC Sales Volume by Type
3.3.1 Global Alpha-GPC Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Alpha-GPC Sales Volume, by Type (2019-2030)
3.3.3 Global Alpha-GPC Sales Volume, by Type (%) (2019-2030)
3.4 Global Alpha-GPC Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical
4.1.2 Health Products
4.2 Global Alpha-GPC Sales Value by Application
4.2.1 Global Alpha-GPC Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Alpha-GPC Sales Value, by Application (2019-2030)
4.2.3 Global Alpha-GPC Sales Value, by Application (%) (2019-2030)
4.3 Global Alpha-GPC Sales Volume by Application
4.3.1 Global Alpha-GPC Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Alpha-GPC Sales Volume, by Application (2019-2030)
4.3.3 Global Alpha-GPC Sales Volume, by Application (%) (2019-2030)
4.4 Global Alpha-GPC Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Alpha-GPC Sales Value by Region
5.1.1 Global Alpha-GPC Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Alpha-GPC Sales Value by Region (2019-2024)
5.1.3 Global Alpha-GPC Sales Value by Region (2025-2030)
5.1.4 Global Alpha-GPC Sales Value by Region (%), (2019-2030)
5.2 Global Alpha-GPC Sales Volume by Region
5.2.1 Global Alpha-GPC Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Alpha-GPC Sales Volume by Region (2019-2024)
5.2.3 Global Alpha-GPC Sales Volume by Region (2025-2030)
5.2.4 Global Alpha-GPC Sales Volume by Region (%), (2019-2030)
5.3 Global Alpha-GPC Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Alpha-GPC Sales Value, 2019-2030
5.4.2 North America Alpha-GPC Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Alpha-GPC Sales Value, 2019-2030
5.5.2 Europe Alpha-GPC Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Alpha-GPC Sales Value, 2019-2030
5.6.2 Asia Pacific Alpha-GPC Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Alpha-GPC Sales Value, 2019-2030
5.7.2 South America Alpha-GPC Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Alpha-GPC Sales Value, 2019-2030
5.8.2 Middle East & Africa Alpha-GPC Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Alpha-GPC Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Alpha-GPC Sales Value
6.2.1 Key Countries/Regions Alpha-GPC Sales Value, 2019-2030
6.2.2 Key Countries/Regions Alpha-GPC Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Alpha-GPC Sales Value, 2019-2030
6.3.2 United States Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Alpha-GPC Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Alpha-GPC Sales Value, 2019-2030
6.4.2 Europe Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Alpha-GPC Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Alpha-GPC Sales Value, 2019-2030
6.5.2 China Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.5.3 China Alpha-GPC Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Alpha-GPC Sales Value, 2019-2030
6.6.2 Japan Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Alpha-GPC Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Alpha-GPC Sales Value, 2019-2030
6.7.2 South Korea Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Alpha-GPC Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Alpha-GPC Sales Value, 2019-2030
6.8.2 Southeast Asia Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Alpha-GPC Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Alpha-GPC Sales Value, 2019-2030
6.9.2 India Alpha-GPC Sales Value by Type (%), 2023 VS 2030
6.9.3 India Alpha-GPC Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lipoid GmbH
7.1.1 Lipoid GmbH Company Information
7.1.2 Lipoid GmbH Introduction and Business Overview
7.1.3 Lipoid GmbH Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Lipoid GmbH Alpha-GPC Product Offerings
7.1.5 Lipoid GmbH Recent Development
7.2 Archimica SpA
7.2.1 Archimica SpA Company Information
7.2.2 Archimica SpA Introduction and Business Overview
7.2.3 Archimica SpA Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Archimica SpA Alpha-GPC Product Offerings
7.2.5 Archimica SpA Recent Development
7.3 Jiangsu Weiqida Pharmaceutical Co
7.3.1 Jiangsu Weiqida Pharmaceutical Co Company Information
7.3.2 Jiangsu Weiqida Pharmaceutical Co Introduction and Business Overview
7.3.3 Jiangsu Weiqida Pharmaceutical Co Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Jiangsu Weiqida Pharmaceutical Co Alpha-GPC Product Offerings
7.3.5 Jiangsu Weiqida Pharmaceutical Co Recent Development
7.4 Suzhou Fushilai Pharmaceutical
7.4.1 Suzhou Fushilai Pharmaceutical Company Information
7.4.2 Suzhou Fushilai Pharmaceutical Introduction and Business Overview
7.4.3 Suzhou Fushilai Pharmaceutical Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Suzhou Fushilai Pharmaceutical Alpha-GPC Product Offerings
7.4.5 Suzhou Fushilai Pharmaceutical Recent Development
7.5 Foman Biopharma
7.5.1 Foman Biopharma Company Information
7.5.2 Foman Biopharma Introduction and Business Overview
7.5.3 Foman Biopharma Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Foman Biopharma Alpha-GPC Product Offerings
7.5.5 Foman Biopharma Recent Development
7.6 JYOUKI Pharmaceutical Co
7.6.1 JYOUKI Pharmaceutical Co Company Information
7.6.2 JYOUKI Pharmaceutical Co Introduction and Business Overview
7.6.3 JYOUKI Pharmaceutical Co Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.6.4 JYOUKI Pharmaceutical Co Alpha-GPC Product Offerings
7.6.5 JYOUKI Pharmaceutical Co Recent Development
7.7 Wuxi Cima Science Co
7.7.1 Wuxi Cima Science Co Company Information
7.7.2 Wuxi Cima Science Co Introduction and Business Overview
7.7.3 Wuxi Cima Science Co Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Wuxi Cima Science Co Alpha-GPC Product Offerings
7.7.5 Wuxi Cima Science Co Recent Development
7.8 Changsha Jiaxi Biotechnology
7.8.1 Changsha Jiaxi Biotechnology Company Information
7.8.2 Changsha Jiaxi Biotechnology Introduction and Business Overview
7.8.3 Changsha Jiaxi Biotechnology Alpha-GPC Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Changsha Jiaxi Biotechnology Alpha-GPC Product Offerings
7.8.5 Changsha Jiaxi Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Alpha-GPC Industrial Chain
8.2 Alpha-GPC Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Alpha-GPC Sales Model
8.5.2 Sales Channel
8.5.3 Alpha-GPC Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Alpha-GPC was estimated to be worth US$ 80.25 million in 2025 and is projected to reach US$ 117 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 132
USD 3950.00
(Single User License)
The global Alpha-GPC market was valued at US$ 80.25 million in 2025 and is anticipated to reach US$ 117 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published Date: 2026-04-18
Pages: 127
USD 2900.00
(Single User License)
The global Alpha-GPC market size was US$ 76.3 million in 2024 and is forecast to a readjusted size of US$ 112 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 76
USD 4250.00
(Single User License)
The global Alpha-GPC market is projected to grow from US$ 76.3 million in 2024 to US$ 112 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 131
USD 4900.00
(Single User License)
The global market for Alpha-GPC was estimated to be worth US$ 76.3 million in 2024 and is forecast to a readjusted size of US$ 112 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 103
USD 3950.00
(Single User License)
The global market for Alpha-GPC was valued at US$ 76.3 million in the year 2024 and is projected to reach a revised size of US$ 112 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published Date: 2025-01-16
Pages: 95
USD 2900.00
(Single User License)
The global Alpha-GPC market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published Date: 2024-04-12
Pages: 88
USD 4900.00
(Single User License)
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias.
Published Date: 2024-01-18
Pages: 86
USD 2900.00
(Single User License)
The global market for Alpha-GPC was estimated to be worth US$ 80.25 million in 2025 and is projected to reach US$ 117 million, growing at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 132
The global Alpha-GPC market was valued at US$ 80.25 million in 2025 and is anticipated to reach US$ 117 million by 2032, at a CAGR of 5.7% from 2026 to 2032.
Published: 2026-04-18
Pages: 127
The global Alpha-GPC market size was US$ 76.3 million in 2024 and is forecast to a readjusted size of US$ 112 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 76
The global Alpha-GPC market is projected to grow from US$ 76.3 million in 2024 to US$ 112 million by 2031, at a CAGR of 5.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 131
The global market for Alpha-GPC was estimated to be worth US$ 76.3 million in 2024 and is forecast to a readjusted size of US$ 112 million by 2031 with a CAGR of 5.7% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 103
The global market for Alpha-GPC was valued at US$ 76.3 million in the year 2024 and is projected to reach a revised size of US$ 112 million by 2031, growing at a CAGR of 5.7% during the forecast period.
Published: 2025-01-16
Pages: 95
The global Alpha-GPC market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Published: 2024-04-12
Pages: 88
L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which has been investigated for its potential for the treatment of Alzheimer's disease and other dementias.
Published: 2024-01-18
Pages: 86
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now